Keyphrases
Induced Apoptosis
100%
LNCaP Cells
100%
Bcl-2 Expression
100%
Cyclooxygenase-2 Inhibitors
100%
NS-398
100%
Cell Viability
33%
Bcl-2 Family Proteins
33%
Human Fetus
33%
Nuclear Morphology
33%
Cyclooxygenase-2
33%
Prostate Fibroblasts
33%
Dose Effect
16%
Cell Apoptosis
16%
LNCaP
16%
Prostate Cancer
16%
Protein Expression
16%
Arachidonic Acid
16%
Prostaglandins
16%
End-labelling
16%
DNA Fragmentation
16%
DNA Modification
16%
Biotin
16%
Terminal Deoxynucleotidyl Transferase
16%
Chromosomal DNA
16%
Eicosanoids
16%
Human Prostate Cancer Cell Lines
16%
Inducible Enzymes
16%
Chromatin Condensation
16%
Nuclear Function
16%
4′,6-diamidino-2-phenylindole
16%
DNA Fragmentation Assay
16%
Biochemistry, Genetics and Molecular Biology
Bcl-2
100%
LNCaP
100%
COX-2 Inhibitor
100%
Cell Viability
40%
Fibroblast
40%
DNA Fragmentation
40%
Cyclooxygenase
40%
Cancer Cell
20%
Enzyme
20%
Protein Expression
20%
Downregulation
20%
Biotin
20%
Arachidonic Acid
20%
Prostaglandin
20%
Terminal Deoxynucleotidyl Transferase
20%
TUNEL Assay
20%
Eicosanoid
20%
Chromatin Condensation
20%
Uridine Triphosphate
20%
Medicine and Dentistry
Programmed Cell Death
100%
Cyclooxygenase 2 Inhibitor
100%
N (2 Cyclohexyloxy 4 Nitrophenyl)methanesulfonamide
100%
Fibroblast
33%
Cell Viability
33%
Cyclooxygenase 2
33%
Protein Bcl 2
33%
Prostate Cancer
16%
Prostate Cancer Cell Line
16%
Protein Expression
16%
Downregulation
16%
Prostaglandin
16%
Arachidonic Acid
16%
TUNEL Assay
16%
DNA Nucleotidylexotransferase
16%
Biotin
16%
Uridine Triphosphate
16%
Icosanoid
16%
DNA Fragmentation
16%
Chromatin Condensation
16%
DNA Fragmentation Assay
16%
Pharmacology, Toxicology and Pharmaceutical Science
COX-2 Inhibitor
100%
NS-398
100%
Protein Bcl 2
33%
Prostate Cancer
33%
Cell Viability
33%
Cyclooxygenase 2
33%
Arachidonic Acid
16%
Prostaglandin
16%
DNA Nucleotidylexotransferase
16%
Biotin
16%
Uridine Triphosphate
16%
Icosanoid
16%